Search - tctmd.com

Displaying 941 - 960 of 4573

Sort: Relevancy | Date

Presentation TCT 2015

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? The Data Says Not as a First-Line Therapy!

Presenter: Kevin J. Beatt, Craig R. Smith, David J. Maron

October 11, 2015

Presentation TCT 2015

Case Presentation: Pretreatment A Patient With Class II Angina and Anterior Wall Ischemia

Presenter: Kevin J. Beatt, Craig R. Smith, Hemal Gada

October 11, 2015

Presentation TCT 2015

How the Case Was Treated

Presenter: Kevin J. Beatt, Craig R. Smith, Javier Escaned

October 11, 2015

Presentation TCT 2015

Does Acute or Late Malapposition Cause Stent Thrombosis?

Presenter: Soo-Jin Kang, Gary S. Mintz

October 11, 2015

Presentation TCT 2015

Case Presentation Pretreatment: MVD Disease With Intermediate SYNTAX Score: How Should This Patient Be Treated?

Presenter: Kevin J. Beatt, Craig R. Smith, Javier Escaned

October 11, 2015

Presentation TCT 2015

Is Deferred Stenting an Option? Rationale for the DEFER-STEMI Trial

Presenter: Timothy D. Henry, Philippe Gabriel Steg, Colin Berry

October 11, 2015

Presentation TCT 2015

Mechanisms and Predictors of Early, Late, and Very Late Stent Thrombosis

Presenter: Soo-Jin Kang, Gary S. Mintz, Lisette Okkels Jensen

October 11, 2015

Presentation TCT 2015

Assessment and Implications of Surgical Inoperability: Who Is at High Risk?

Presenter: Kevin J. Beatt, Craig R. Smith, Robert W. Yeh

October 11, 2015

Presentation TCT 2015

New Insights From the Stent for Life Initiative

Presenter: Timothy D. Henry, Philippe Gabriel Steg, Petr Kala

October 11, 2015

Presentation TCT 2015

Stents in CTO: If I Get It Open, Will It Stay Open?

Presenter: Etsuo Tsuchikane, Gerald S. Werner, Sunao Nakamura

October 11, 2015

Presentation TCT 2015

Mechanisms and Predictors and Treatment of In-Stent Restenosis

Presenter: Soo-Jin Kang, Gary S. Mintz

October 11, 2015

Presentation TCT 2015

Functional Risk Scoring: Fame 3 and Beyond

Presenter: Kevin J. Beatt, Craig R. Smith, William F. Fearon

October 11, 2015

Presentation TCT 2015

Are Risk Scores Practical and Useful to Differentiate PCI vs CABG?

Presenter: Kevin J. Beatt, Craig R. Smith, Davide Capodanno

October 11, 2015

Presentation TCT 2015

The Case for Hybrid Revascularization: Combining the LIMA With the LAD With Stenting of Non-LAD Lesions

Presenter: Taehoon Ahn, Robert C. Welsh, Leif Thuesen

October 11, 2015

Presentation TCT 2015

The SYNTAX Score in Clinical Practice: Promise and Pitfalls

Presenter: Kevin J. Beatt, Craig R. Smith, Philippe Généreux

October 11, 2015

Presentation TCT 2015

Management Strategies for SFA/Popliteal In-Stent Restenosis

Presenter: Hans Krankenberg, Lindsay S. Machan

October 11, 2015

Presentation TCT 2015

Case Resolution: How Did We Treat Our STEMI Patient With Abundant Thrombus (and What Were the Long-term Outcomes)?

Presenter: Dariusz Dudek, Robert J. de Winter, Arif Al Nooryani

October 11, 2015

Presentation TCT 2015

Critical Analysis of Current Guidelines on Multivessel Revascularization: Are They Up to Date?

Presenter: Kevin J. Beatt, Craig R. Smith, Marie-Claude Morice

October 11, 2015

Presentation TCT 2015

Case Introduction: A STEMI Patient With Abundant Thrombus

Presenter: Dariusz Dudek, Robert J. de Winter, Arif Al Nooryani

October 11, 2015

Presentation TCT 2015

In Which Patients (if Any) Should BMS Be Used in 2015? Evidence and Common Sense

Presenter: John A. Bittl, E. Magnus Ohman, Marco Valgimigli

October 11, 2015

Advertisement

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? The Data Says Not as a First-Line Therapy!

Case Presentation: Pretreatment A Patient With Class II Angina and Anterior Wall Ischemia

How the Case Was Treated

Does Acute or Late Malapposition Cause Stent Thrombosis?

Case Presentation Pretreatment: MVD Disease With Intermediate SYNTAX Score: How Should This Patient Be Treated?

Is Deferred Stenting an Option? Rationale for the DEFER-STEMI Trial

Mechanisms and Predictors of Early, Late, and Very Late Stent Thrombosis

Assessment and Implications of Surgical Inoperability: Who Is at High Risk?

New Insights From the Stent for Life Initiative

Stents in CTO: If I Get It Open, Will It Stay Open?

Mechanisms and Predictors and Treatment of In-Stent Restenosis

Functional Risk Scoring: Fame 3 and Beyond

Are Risk Scores Practical and Useful to Differentiate PCI vs CABG?

The Case for Hybrid Revascularization: Combining the LIMA With the LAD With Stenting of Non-LAD Lesions

The SYNTAX Score in Clinical Practice: Promise and Pitfalls

Management Strategies for SFA/Popliteal In-Stent Restenosis

Case Resolution: How Did We Treat Our STEMI Patient With Abundant Thrombus (and What Were the Long-term Outcomes)?

Critical Analysis of Current Guidelines on Multivessel Revascularization: Are They Up to Date?

Case Introduction: A STEMI Patient With Abundant Thrombus

In Which Patients (if Any) Should BMS Be Used in 2015? Evidence and Common Sense

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content